Harrow Health, Inc. logo

Harrow Health, Inc.

NASDAQ:HROW

Overview | Financials
Company Name Harrow Health, Inc.
Symbol HROW
Currency USD
Price 45.14
Market Cap 1,601,698,106
Dividend Yield 0%
52-week-range 7.6 - 45.78
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Mark L. Baum J.D.
Website https://www.harrowinc.com

An error occurred while fetching data.

About Harrow Health, Inc.

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics

Related Stocks

Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

ORMP

2.49 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

66.73 USD

Scholar Rock Holding Corporation logo

Scholar Rock Holding Corporation

SRRK

8.57 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

7.06 USD

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

0.835 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.96 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

7.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD